...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Long covid trials
9
Jul 31, 2023 07:03PM
2
Aug 01, 2023 09:53AM
2
Aug 01, 2023 10:08AM
3
Aug 01, 2023 04:58PM
7
Aug 02, 2023 06:57PM
1
Aug 03, 2023 07:23AM
3
Aug 03, 2023 10:41AM
1
Aug 03, 2023 11:20AM
1
Aug 03, 2023 08:56PM
7
Aug 03, 2023 09:01PM
4
Aug 03, 2023 10:05PM

Aug 08, 2023 12:42PM
1
Aug 08, 2023 01:35PM
1
Aug 08, 2023 01:40PM

" Hi xxxxxx,

Thank you for your question. Our clinical and business teams evaluated the NIH long Covid program when it was announced and determined that it would not be advantageous for ResverLogix to participate in the program. My understanding is that it would be very difficult –though perhaps not impossible– for a Canadian company to participate in the program, as it is intended primarily for American companies. The requirements for us accessing those funds would have meant cost increases to our planned Post COVID-19 Conditions trial in excess of the value of any funding NIH would have provided. 

Best regards,

Chris "


Aug 08, 2023 04:17PM
Share
New Message
Please login to post a reply